Quick Answer
ORAMED PHARMACEUTICALS INC. reported Total Revenue of $2.00 million for fiscal year 2025.
ORAMED PHARMACEUTICALS INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.00M | +49.3% |
| 2023 | $1.34M | -50.4% |
| 2022 | $2.70M | +0.0% |
| 2021 | $2.70M | -0.3% |
| 2020 | $2.71M | +0.3% |
| 2019 | $2.70M | +10.4% |
| 2018 | $2.45M | -0.3% |
| 2017 | $2.46M | +283.2% |
| 2016 | $641.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | $2.00M | — | +196.7% |
| June 30, 2023 | $674.0K | +0.0% | +1.2% |
| March 31, 2023 | $666.0K | +0.0% | -2.3% |
| September 30, 2022 | $682.0K | +0.0% | +1.2% |
| June 30, 2022 | $674.0K | +0.0% | +1.2% |
| March 31, 2022 | $666.0K | +0.0% | -1.2% |
| November 30, 2021 | $674.0K | — | -1.2% |
| September 30, 2021 | $682.0K | — | +1.2% |
- ORAMED PHARMACEUTICALS INC. showed an increase of +49.3% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, ORAMED PHARMACEUTICALS INC.’s total revenue has grown by 212.0% (from $641.0 thousand to $2.00 million).
- The most recent figure is from ORAMED PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: